HDL Particle Size and Functional Heterogeneity.

about

β3-Adrenoceptor activation upregulates apolipoprotein A-I expression in HepG2 cells, which might further promote cholesterol efflux from macrophage foam cells.High-density lipoprotein metabolism and reverse cholesterol transport: strategies for raising HDL cholesterol.

P2860

Q37691638-E303E753-7B2A-4D45-B57C-5F048C40290B Q45870343-0A183C03-B0F4-4A80-A356-7A0B96D9F9FD

P2860

HDL Particle Size and Functional Heterogeneity.

Item

http://www.wikidata.org/entity/Q47276390

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

HDL Particle Size and Functional Heterogeneity.

@en

HDL Particle Size and Functional Heterogeneity.

@nl

type

Item

label

HDL Particle Size and Functional Heterogeneity.

@en

HDL Particle Size and Functional Heterogeneity.

@nl

prefLabel

HDL Particle Size and Functional Heterogeneity.

@en

HDL Particle Size and Functional Heterogeneity.

@nl

P1476

HDL Particle Size and Functional Heterogeneity.

@en

P2093

Sergio Fazio

http://www.w3.org/2001/XMLSchema#string

P2860

Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease

Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study

Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis.

HDL cholesterol efflux capacity and incident cardiovascular events.

Inflammatory remodeling of the HDL proteome impairs cholesterol efflux capacity

Association of HDL cholesterol efflux capacity with incident coronary heart disease events: a prospective case-control study

Novel Pathways of Apolipoprotein A-I Metabolism in High-Density Lipoprotein of Different Sizes in Humans

Proteomic analysis of HDL from inbred mouse strains implicates APOE associated with HDL in reduced cholesterol efflux capacity via the ABCA1 pathway

Niacin Therapy Increases High-Density Lipoprotein Particles and Total Cholesterol Efflux Capacity But Not ABCA1-Specific Cholesterol Efflux in Statin-Treated Subjects.

Targeted Proteomics Identifies Paraoxonase/Arylesterase 1 (PON1) and Apolipoprotein Cs as Potential Risk Factors for Hypoalphalipoproteinemia in Diabetic Subjects Treated with Fenofibrate and Rosiglitazone.

P304

704-707

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1161/CIRCRESAHA.116.309506

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

119

http://www.w3.org/2001/XMLSchema#string

P50

Nathalie Pamir

P577

2016-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27587407

http://www.w3.org/2001/XMLSchema#string

P932

5971193

http://www.w3.org/2001/XMLSchema#string

HDL Particle Size and Functional Heterogeneity.

about

P2860

P2860

HDL Particle Size and Functional Heterogeneity.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932